NSP vs. CCRN, RHI, KFY, ASGN, MAN, BBSI, HSII, KFRC, KELYA, and TBI
Should you be buying Insperity stock or one of its competitors? The main competitors of Insperity include Cross Country Healthcare (CCRN), Robert Half (RHI), Korn/Ferry International (KFY), ASGN (ASGN), ManpowerGroup (MAN), Barrett Business Services (BBSI), Heidrick & Struggles International (HSII), Kforce (KFRC), Kelly Services (KELYA), and TrueBlue (TBI).
Insperity vs. Its Competitors
Insperity (NYSE:NSP) and Cross Country Healthcare (NASDAQ:CCRN) are both business services companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, dividends, earnings and risk.
93.4% of Insperity shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 5.3% of Insperity shares are owned by insiders. Comparatively, 4.9% of Cross Country Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Insperity has a net margin of 0.95% compared to Cross Country Healthcare's net margin of -1.41%. Insperity's return on equity of 52.17% beat Cross Country Healthcare's return on equity.
Insperity has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Insperity, indicating that it is currently the more affordable of the two stocks.
Insperity has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500.
In the previous week, Cross Country Healthcare had 1 more articles in the media than Insperity. MarketBeat recorded 4 mentions for Cross Country Healthcare and 3 mentions for Insperity. Cross Country Healthcare's average media sentiment score of 0.70 beat Insperity's score of 0.59 indicating that Cross Country Healthcare is being referred to more favorably in the news media.
Insperity presently has a consensus price target of $80.00, suggesting a potential upside of 36.98%. Cross Country Healthcare has a consensus price target of $17.93, suggesting a potential upside of 48.55%. Given Cross Country Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Cross Country Healthcare is more favorable than Insperity.
Summary
Insperity beats Cross Country Healthcare on 10 of the 15 factors compared between the two stocks.
Get Insperity News Delivered to You Automatically
Sign up to receive the latest news and ratings for NSP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Insperity Competitors List
Related Companies and Tools
This page (NYSE:NSP) was last updated on 7/12/2025 by MarketBeat.com Staff
Free NSP Stock Alerts